The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Hepatitis and HIV CoinfectionHepatitis and HIV Coinfection
Rollover images to visit our other forums!
  • Email Email
  • Glossary Glossary

Hepatitis C and Crohn's
Oct 25, 2001

\I am a white female, age 33, with genotype 1b, ALT 30, AST 28 and 440,000 copies. I also suffer from a mild case of Crohn's disease for which I am taking Asacol (sulfasalazine) as a preventative. Can you please tell me your toughts of my chances of being "cured" with my condtion and will the Asacol have any effect with treatment outcome? Lastly, what treatment would you recommend. I thank you in advance for any help or suggestions you could offer.

Response from Dr. Rodriguez-Torres

Your Crohn's disease is a different condition ,but is also an immune process as HCV.I am not aware of any report of agravation or worsening of this condition with interferon therapy,but although possible ,it may be rare and not significant.Anyway be sure you are stable before you start hepatitis therapy,and follow closely. Genotype i ,low viral load:sustained response rate with Peg-Intron and RBV-41% ,but this data is not reported ,appears in the drug insert.Pegasys and RBV -46%,in intention to treat analysis;this number is higher in the patients that actually received treatment.Regarding side effects;Peg-Intron is worse than Rebetron and,Pagasys is better. Your best choice is clear.

Side Effects & Cure Rate Using Pegylated Interferon for Hep C
Level of hep c

  • Email Email
  • Glossary Glossary



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint